Your contact person
Manager PR & Communications Jan Phillip Denkers
Topas Therapeutics Extends Series B
Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today ...
Read more …